Those of you who work in breast screening will most likely have heard of the Sloane Project – named in memory of highly regarded pathologist Professor John Sloane.
It is an audit of screen detected non-invasive carcinomas and atypical hyperplasias of the breast whose aim is to better understand early developing conditions including ductal carcinoma in situ (DCIS) which can lead to breast cancer if untreated.
In the past, clinicians weren’t sure of the best ways to treat women found with non-invasive breast disease, which is why the Sloane Project was set up.
This project has been running since 2003 and involves breast screening units sending us their data.
If you’d like to find out more you can read about the project in a previous blog we wrote.
Moving to GOV.UK
The Sloane Project website is one of the last screening sites inherited by PHE that hasn't yet been moved onto GOV.UK.
Like all these transition projects, we've been careful to involve our users in the process of moving the information across to find out what we still need and what we don't.
We've tried as much as we can to put ourselves in the shoes of the professionals who use it, asking what they find useful and think could be better.
We have widely consulted with our stakeholders, including the Sloane Project Steering Group.
As a result, the process has helped us to clarify:
- the information we need to provide on the new website
- what may no longer be required
- what may only be a “nice to have”
What we’ll do next
The next step is to start looking at how how many people are using the current site – which pages are most and least popular – and which ones are hardly used at all.
This will help us to decide whether certain pages are no longer useful for professionals and the public.
Once we’ve done that, we’re going to start the process of moving the information across.
We’re hoping to make the move to GOV.UK by autumn 2018, but we’ll keep you updated via our screening blog.
If you're a regular user of the current website and would like to let us know what you find most useful, please feel free to contact us via the PHE Screening helpdesk.